Jan 12, 2011 | CenExel JBR, Clinical Trial, Vaccines
Jan 12, 2011CenExel JBR, Clinical Trial, Vaccines
At CenExel Clinical Research, our top priorities are the safety and health of our patients and employees. For our Centers of Excellence to provide the highest quality of clinical research, we established and maintain a COVID-19 Task Force with representatives from every Center. The Task Force is charged with continuous monitoring of the pandemic and providing guidance and communication.
Our clinical operations continue, and we have implemented the following additional safety measures:
We will continue to monitor the current situation, coordinate with the proper authorities, and update our policies and procedures as needed to ensure the safety of our patients and employees.